EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.712
https://www.valueinhealthjournal.com/article/S1098-3015(24)00827-1/fulltext
Title :
EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00827-1&doi=10.1016/j.jval.2024.03.712
First page :
Section Title :
Open access? :
No
Section Order :
10181